At a glance
ClinicalIndex Comparison RecordN/ACompleted· 242 enrolled
Drug / intervention
Cerene(R) Cryotherapy Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A CLinical Study to Evaluate the Safety And Effectiveness of the CeRene DevIce to Treat HeavY Menstrual Bleeding
In Brief
A clinical study evaluating Cerene(R) Cryotherapy Device for Menorrhagia. Completed, enrolled 242 participants across 12 sites in 3 countries.
Detailed Summary
The purpose of the study is to evaluate the safety and effectiveness of the Cerene Cryotherapy Device in reducing menstrual bleeding in women with heavy menstrual bleeding (menorrhagia) due to benign causes for whom child bearing is complete.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenorrhagia
CountriesCanada, Mexico, United States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedJul 2016
Primary CompletionApr 2018
Study CompletionMay 2020
TodayJul 2026
First PostedJul 25, 2016
Enrollment StartApr 1, 2016
Primary CompletionApr 1, 2018
Study CompletionMay 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 9.9 years ago
Interventions
Cerene(R) Cryotherapy Devicedevice